Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

AGM Trading Statement

29 Apr 2021 07:00

RNS Number : 9670W
Fisher (James) & Sons plc
29 April 2021
Β 

29 April 2021

Β 

James Fisher and Sons plc

AGM Trading Statement

Β 

James Fisher and Sons plc ("James Fisher" or the "Group"), the leading marine services provider, issues its trading statement for the first quarter of 2021 ("the period") prior to its Annual General Meeting to be held today at 11.00 am.

Β 

The Group performed in line with management expectations in the first quarter, which is typically the weakest quarter for the Group. Revenue for the period was Β£109.3m (2020: Β£129.4m).

Β 

Offshore Oil and Specialist Technical performed well and, in aggregate, offset reduced volumes in Tankships. Tendering for oil and gas decommissioning projects has been strong throughout the period with significant programme awards received in the Middle East, North Sea and Far East.

Β 

In Marine Support, ship-to-ship transfers were in line with expectations. Whilst activity levels remain subdued due to Covid-19 restrictions, tendering volumes for renewables and oil & gas projects have been strong. Notable project wins include a critical cable termination and testing contract for Triton Knoll, which follows the removal of unexploded ordinance in preparation for the construction of a wind farm. Also, Ørsted has awarded a major cathodic protection programme for the Walney 2 wind farm off the Cumbrian coast.

Β 

Despite the continuing impact of Covid-19, the Board believes that the Group is on track to deliver improved performance over that of 2020, with a weighting towards the second half.

Β 

The Group has a resilient business model with a broad spread of end markets, customers and geographies, supported by a strong track record of converting its operating profit into cash. The ongoing strategic review confirms the fundamental strengths of the Group and has also identified scope for significant financial and operational improvement. The goal is to improve the quality of our business by focusing on structurally growing markets, improving operating margins, increasing returns and sustainably delivering value for all stakeholders.

Β 

James Fisher will host a Capital Markets Day on the afternoon of 29 June 2021 to lay out the strategic direction for the Group.

Β 

Contacts

Β 

James Fisher and Sons plc

Β 

Eoghan O'Lionaird

CEO

020 7614 9508

FTI Consulting

Β 

Richard Mountain

Β 

0203 727 1374

Β 

Β 

Forward-looking statements

Β 

This announcement contains statements which are, or may be deemed to be, "forward-looking statements" which are prospective in nature. All statements other than statements of historical fact are forward-looking statements. By their nature, forward-looking statements are subject to a number of known and unknown risks, uncertainties and contingencies, and actual results and events could differ materially from those currently being anticipated as reflected in such statements. Factors may cause future outcomes to differ from those foreseen or implied, many of which are beyond James Fisher's control or influence. Any forward-looking statements speak only as of the date of this announcement and have not been audited or otherwise independently verified. Past performance should not be taken as an indication or guarantee of future results and no representation or warranty, express or implied, is made regarding future performance. Except as required by any applicable law or regulation, James Fisher expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained in this announcement to reflect any change in the Group's expectations or any change in events, conditions or circumstances on which any such statement is based after the date of this announcement, or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on any forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTQVLFLFZLBBBZ
Date   Source Headline
22nd May 202612:22 pmRNS-RNotice of Defence Division Investor Event
18th May 20269:30 amRNSDirector/PDMR Shareholding
13th May 20261:48 pmRNSResult of AGM
22nd Apr 202611:15 amRNSDirector/PDMR Shareholding
8th Apr 20269:28 amRNSAnnual Report and Accounts and Notice of AGM
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
12th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
16th Feb 20267:00 amRNSNotice of Analyst and Investor Presentations
13th Feb 20263:10 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
27th Jan 20262:05 pmRNSHolding(s) in Company
15th Jan 20262:00 pmRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20254:08 pmRNSHolding(s) in Company
26th Sep 20258:35 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSHalf Year Results
21st Aug 20257:00 amRNSNotice of Analyst and Investor Presentations
1st Aug 20258:00 amRNSTotal Voting Rights and Share Capital
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
16th Jul 20257:00 amRNSTotal Voting Rights and Share Capital
16th Jun 20254:35 pmRNSBlock listing six monthly return
23rd May 202511:46 amRNSBlock Listing Application
13th May 20252:36 pmRNSResults of Annual General Meeting
6th May 202510:39 amRNSNotification of Directors' Interest in Shares
28th Apr 20252:33 pmRNSNotification of Directors' Interest in Shares
4th Apr 20259:30 amRNSAnnual Report and Accounts 2024 and Notice of AGM
20th Mar 20257:00 amRNSFull Year Results
14th Mar 20259:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20257:56 amRNSHolding(s) in Company
16th Jan 20259:58 amRNSHolding(s) in Company
16th Dec 202410:59 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Sep 20243:35 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSSigning of £95m of committed bank facilities
10th Sep 20247:00 amRNSHalf year results
6th Sep 20242:10 pmRNSCompletion of Disposal of Martek Holdings Limited
8th Jul 20244:19 pmRNSHolding(s) in Company
8th Jul 202410:04 amRNSCompletion of RMSpumptools Disposal
28th Jun 20249:26 amRNSDirector Declaration
17th Jun 202411:32 amRNSBlock listing six monthly return
13th Jun 20246:15 pmRNSResults of the General Meeting
12th Jun 20241:43 pmRNSNotification of Directors' Interests in Shares
30th May 20244:48 pmRNSResults of Annual General Meeting
30th May 20243:34 pmRNSDirector Declaration
24th May 20243:18 pmRNSPublication of Circular and Notice of GM
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.